AKBA EBITDA | AKEBIA THERAPEUTICS, INC.

AKEBIA THERAPEUTICS, INC. (AKBA) EBITDA

2026-06-30: Basis Reported; EBITDA (m); Operating income -$6.33M; Depreciation and amortization (m).
2026-03-31: Basis Reported; EBITDA (m); Operating income -$4.70M; Depreciation and amortization (m).
2025-09-30: Basis Reported; EBITDA (m); Operating income $4.45M; Depreciation and amortization (m).
2025-06-30: Basis Reported; EBITDA (m); Operating income $14.09M; Depreciation and amortization (m).

Complete source-backed ebitda history.

Available history: 2014-12-31 to 2022-12-31
Data captured: 2026-09-04

Historical EBITDA

EBITDA 3 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-06-30	Reported	(m)	-$6.33M	(m)	$49.13M	(m)	$1.08M*	$3.52M*	(m)	$14.06M	$28.17M	$70.00K
2026-03-31	Reported	(m)	-$4.70M	(m)	$53.54M	(m)	$62.00K	-$21.21M	(m)	$14.81M	$30.44M	$126.00K
2025-09-30	Reported	(m)	$4.45M	(m)	$58.77M	(m)	$77.00K*	$28.11M*	(m)	$14.94M	$29.09M	$615.00K
2025-06-30	Reported	(m)	$14.09M	(m)	$62.47M	(m)	$126.00K*	$22.34M*	(m)	$11.01M	$26.55M	$0.00
2025-03-31	Reported	(m)	$13.51M	(m)	$57.34M	(m)	$18.00K	-$13.59M	(m)	$9.75M	$25.74M	$0.00
2024-09-30	Reported	(m)	-$12.51M	(m)	$37.43M	(m)	$2.00K*	-$6.70M*	(m)	$8.49M	$26.52M	$0.00
2024-06-30	Reported	(m)	-$8.72M	(m)	$43.65M	(m)	$29.00K*	-$10.07M*	(m)	$7.65M	$26.92M	(m)
2024-03-31	Reported	(m)	-$14.94M	(m)	$32.61M	(m)	$0.00	-$19.43M	(m)	$9.73M	$25.44M	(m)
2023-09-30	Reported	(m)	-$13.04M	(m)	$42.05M	(m)	$0.00*	-$7.17M*	(m)	$13.33M	$22.71M	(m)
2023-06-30	Reported	(m)	-$9.00M	(m)	$56.38M	(m)	$0.00*	$3.63M*	(m)	$20.20M	$27.04M	(m)
2023-03-31	Reported	(m)	-$25.60M	(m)	$40.01M	(m)	$0.00	-$17.54M	(m)	$19.69M	$25.05M	(m)
2022-09-30	Reported	(m)	-$50.41M	(m)	$48.71M	(m)	$0.00*	$33.80M*	(m)	$28.03M	$31.89M	(m)
2022-06-30	Reported	(m)	$34.08M	(m)	$126.36M	(m)	$0.00*	-$30.66M*	(m)	$26.03M	$32.24M	(m)
2022-03-31	Reported	(m)	-$59.58M	(m)	$61.70M	(m)	$114.00K	-$21.62M	(m)	$43.83M	$44.57M	(m)
2021-09-30	Reported	(m)	-$54.89M	(m)	$48.76M	(m)	$0.00*	-$56.27M*	(m)	$40.47M	$46.36M	(m)
2021-06-30	Reported	(m)	-$79.34M	(m)	$52.91M	(m)	$0.00*	-$63.14M*	(m)	$37.21M	$41.65M	(m)
2021-03-31	Reported	(m)	-$64.94M	(m)	$52.30M	(m)	$59.00K	-$70.75M	(m)	$40.61M	$41.33M	(m)
2020-12-31	Reported	(m)	-$85.40M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	$0.00
2020-09-30	Reported	(m)	-$58.09M	(m)	$59.99M	(m)	-$45.00K*	-$27.24M*	(m)	$46.86M	$40.17M	$0.00
2020-06-30	Reported	(m)	-$173.82M	(m)	$90.14M	(m)	$45.00K*	$37.22M*	(m)	$52.82M	$35.48M	$0.00
2020-03-31	Reported	-$58.6M	(m)	(m)	(m)	-66.23%	$0.00	-$89.59M	$18.61M	$81.23M	$37.98M	$0.00
2019-12-31	Reported	-$94.31M	(m)	(m)	(m)	-135.58%	(m)	(m)	(m)	(m)	(m)	-$1.75M
2019-09-30	Reported	-$55.27M*	-$55.91M	$633.00K*	$91.98M	-60.09%*	$2.53M*	$10.99M*	$29.16M	$74.51M	$34.18M	-$1.28M
2019-06-30	Reported	-$58.94M*	-$59.52M	$587.00K*	$100.80M	-58.47%*	$1.98M*	-$38.37M*	$28.57M	$85.69M	$36.07M	-$845.00K
2019-03-31	Reported	-$75.53M	(m)	(m)	(m)	-103.94%	$1.93M	-$137.93M	$22.16M	$82.35M	$34.29M	-$2.76M
2018-12-31	Reported	-$89.9M	(m)	(m)	(m)	-150.20%	(m)	(m)	(m)	(m)	(m)	-$28.34M
2018-09-30	Reported	-$27.62M*	-$27.84M	$225.00K*	$53.17M	-51.94%*	$307.00K*	-$12.46M*	(m)	$70.63M	$10.38M	$0.00
2018-06-30	Reported	-$35.45M*	-$35.66M	$214.00K*	$48.79M	-72.65%*	$173.00K*	$9.00M*	(m)	$71.92M	$12.54M	$0.00
2018-03-31	Reported	-$24.3M	(m)	(m)	(m)	-52.90%	$296.00K	-$20.33M	(m)	$61.40M	$9.02M	$0.00
2017-12-31	Reported	$14.81M	(m)	(m)	(m)	16.35%	(m)	(m)	(m)	(m)	(m)	(m)
2017-09-30	Reported	-$24.01M*	-$24.18M	$167.00K*	$41.28M	-58.16%*	$597.00K*	-$54.62M*	(m)	$58.71M	(m)	$0.00
2017-06-30	Reported	-$22.02M*	-$22.14M	$118.00K*	$28.52M	-77.20%*	$148.00K*	(m)	(m)	$43.75M	(m)	$0.00
2017-03-31	Reported	-$44.84M	(m)	(m)	(m)	(m)	$427.00K	(m)	(m)	$60.05M	(m)	$0.00
2016-12-31	Reported	-$37.92M	(m)	(m)	(m)	-2470.36%	(m)	(m)	(m)	(m)	(m)	(m)
2016-09-30	Reported	-$36.09M*	-$36.18M	$94.00K*	(m)	(m)	$1.26M*	(m)	(m)	$31.24M	(m)	$0.00
2016-06-30	Reported	-$36.14M*	-$36.19M	$46.00K*	(m)	(m)	$1.25M*	(m)	(m)	$30.88M	(m)	$0.00
2016-03-31	Reported	-$26.01M	(m)	(m)	(m)	(m)	$109.00K	(m)	(m)	$20.23M	(m)	$0.00
2015-12-31	Reported	-$20.04M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-09-30	Reported	-$19.64M*	-$19.68M	$35.00K*	(m)	(m)	$115.00K*	(m)	(m)	$15.60M	(m)	$0.00
2015-06-30	Reported	(m)	-$10.89M	(m)	(m)	(m)	$27.00K*	(m)	(m)	$6.50M	(m)	$0.00
2015-03-31	Reported	(m)	-$10.90M	(m)	(m)	(m)	$200.00K	(m)	(m)	$6.66M	(m)	$0.00
2014-12-31	Reported	(m)	-$10.61M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2014-09-30	Reported	(m)	-$9.58M	(m)	(m)	(m)	$37.00K*	(m)	(m)	$6.65M	(m)	$0.00
2014-06-30	Reported	(m)	-$7.84M	(m)	(m)	(m)	$29.00K*	(m)	(m)	$5.53M	(m)	$0.00
2014-03-31	Reported	(m)	-$9.91M	(m)	(m)	(m)	$142.00K	(m)	(m)	$6.16M	(m)	$0.00
2013-12-31	Reported	(m)	-$6.20M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2013-09-30	Reported	(m)	-$4.03M	(m)	(m)	(m)	(m)	(m)	(m)	$3.24M	(m)	$0.00
2013-06-30	Reported	(m)	-$3.12M	(m)	(m)	(m)	(m)	(m)	(m)	$2.45M	(m)	$0.00
2013-03-31	Reported	(m)	-$2.58M	(m)	(m)	(m)	(m)	(m)	(m)	$1.90M	(m)	$0.00

EBITDA 12 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2025-12-31	Reported	(m)	$23.50M	(m)	$236.20M	(m)	$291.00K	$67.99M	(m)	$62.36M	$107.48M	$1.62M
2024-12-31	Reported	(m)	-$50.47M	(m)	$160.18M	(m)	$33.00K	-$40.66M	(m)	$37.65M	$106.55M	$0.00
2023-12-31	Reported	(m)	-$46.26M	(m)	$194.62M	(m)	$0.00	-$23.38M	(m)	$63.08M	$100.23M	$0.00
2022-12-31	Reported	-$79.13M	(m)	(m)	(m)	-27.05%	$114.00K	-$73.15M	(m)	$129.99M	$138.60M	$0.00
2021-12-31	Reported	-$263.39M	(m)	(m)	(m)	-123.32%	$59.00K	-$252.97M	(m)	$147.85M	$174.14M	$0.00
2021-09-30	Rolling	(m)	-$284.57M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2021-06-30	Rolling	(m)	-$287.77M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2021-03-31	Rolling	(m)	-$382.25M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2020-12-31	Reported	-$374.37M	(m)	(m)	(m)	-126.77%	$317.00K	-$110.39M	(m)	$218.49M	$154.10M	$0.00
2020-12-31	Rolling	(m)	-$376.44M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	$0.00*
2020-09-30	Rolling	(m)	-$385.93M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	-$1.75M*
2020-06-30	Rolling	(m)	-$383.74M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	-$3.03M*
2020-03-31	Rolling	(m)	-$269.44M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	-$3.87M*
2019-12-31	Reported	-$284.04M	(m)	(m)	(m)	-84.79%	$6.66M	-$257.44M	$108.94M	$322.97M	$149.46M	-$6.63M
2019-12-31	Rolling	(m)	-$286.29M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	-$6.63M*
2019-09-30	Rolling	(m)	-$281.56M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	-$33.22M*
2019-06-30	Rolling	(m)	-$253.49M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	-$31.94M*
2019-03-31	Rolling	(m)	-$229.63M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	-$31.09M*
2018-12-31	Reported	-$177.26M	(m)	(m)	(m)	-85.33%	$1.61M	-$97.49M	$6.25M	$291.01M	$87.06M	-$28.34M
2018-12-31	Rolling	(m)	-$178.16M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	-$28.34M*
2018-09-30	Rolling	(m)	-$73.39M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-06-30	Rolling	(m)	-$69.73M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-03-31	Rolling	(m)	-$56.20M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-12-31	Reported	-$76.06M	(m)	(m)	(m)	-41.97%	$1.62M	-$56.16M	(m)	$230.89M	$27.01M	(m)
2017-12-31	Rolling	(m)	-$76.67M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-09-30	Rolling	(m)	-$129.33M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-06-30	Rolling	(m)	-$141.33M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-03-31	Rolling	(m)	-$155.39M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-12-31	Reported	-$136.16M	(m)	(m)	(m)	-8870.62%	$2.66M	$57.91M	(m)	$115.78M	$22.21M	(m)
2016-12-31	Rolling	(m)	-$136.46M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-09-30	Rolling	(m)	-$118.47M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-06-30	Rolling	(m)	-$101.96M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-03-31	Rolling	(m)	-$76.66M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-12-31	Reported	-$61.42M	(m)	(m)	(m)	(m)	$414.00K	(m)	(m)	$43.02M	(m)	(m)
2015-12-31	Rolling	(m)	-$61.51M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-09-30	Rolling	(m)	-$52.07M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-06-30	Rolling	(m)	-$41.98M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-03-31	Rolling	(m)	-$38.93M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2014-12-31	Reported	-$37.89M	(m)	(m)	(m)	(m)	$229.00K	(m)	(m)	$23.26M	(m)	(m)
2014-12-31	Rolling	(m)	-$37.94M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2014-09-30	Rolling	(m)	-$33.53M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2014-06-30	Rolling	(m)	-$27.98M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2014-03-31	Rolling	(m)	-$23.27M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2013-12-31	Reported	(m)	-$15.93M	(m)	(m)	(m)	$19.00K	(m)	(m)	$8.90M	(m)	(m)
2013-12-31	Rolling	(m)	-$15.93M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2012-12-31	Reported	(m)	-$8.52M	(m)	(m)	(m)	(m)	(m)	(m)	$5.63M	(m)	(m)

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Lyell Immunopharma, Inc. (LYEL)	United States	$0.248B	-1.32
Pyxis Oncology, Inc. (PYXS)	United States	$0.244B
Greenwich LifeSciences, Inc. (GLSI)	United States	$0.267B	-15.02
Entrada Therapeutics, Inc. (TRDA)	United States	$0.243B	-1.73
Cue Biopharma, Inc. (CUE)	United States	$0.243B	-1.01
MACROGENICS INC (MGNX)	United States	$0.242B	-20.11
Mereo BioPharma Group plc (MREO)		$0.269B	-9.41
Camp4 Therapeutics Corp (CAMP)	United States	$0.240B	-2.12
Sionna Therapeutics, Inc. (SION)	United States	$0.236B	-20.37
SIGA TECHNOLOGIES INC (SIGA)	United States	$0.234B	-93.33